Adjusting insulin doses to prevent hypoglycemia

Verified sources Updated: October 2, 2026 9 min read

The time at which hypoglycemia occurs can show which insulin dose may need adjusting. Only one dose is changed at a time, together with your doctor, and the effect is then followed for a few days.

overnight or in the morning
suspect the basal insulin
2–3 hours after a meal
suspect the meal dose
after corrections
suspect the sensitivity factor

Which insulin dose most often causes hypoglycemia?

It depends on when the hypoglycemic episode happens. A basal insulin dose that is too high raises the risk of hypoglycemia during the night, in the morning on an empty stomach and sometimes between meals. A meal dose that is too high causes hypoglycemia two or three hours after you eat [1].

Repeated corrections are the third cause, and the easiest to miss. Correction doses add up on top of each other, and their combined effect sometimes shows up later [2]. The time at which hypoglycemia occurs is the best clue to the dose that needs changing.

How do you recognize a basal insulin dose that is too high?

By a telling pattern. Your blood glucose falls during the night or three hours after a meal, with no obvious cause. You feel you need to eat so as not to slip into hypoglycemia, and if you skip a meal, your blood glucose keeps falling on its own.

It is checked together with your doctor, through a period of supervised fasting or by carefully reading the sensor reports [3]. A correct basal insulin dose keeps blood glucose almost flat when you are not eating or exercising, including during sleep [1]. If the line keeps going down, the basal insulin dose may be too high.

What is the active insulin left in the body?

It is the amount of insulin left over from an earlier dose that is still working. A rapid-acting insulin analog usually works for three to five hours, with its peak action within the first two hours [4]. Pumps and many apps can display this amount if they are set up correctly [5].

It is a very useful number when you are thinking about a correction. If your active insulin is high, remember that a new correction adds on top of it. Ignoring it can explain many episodes of hypoglycemia that seem to have no cause [5].

Why do corrections given too close together cause hypoglycemia?

Their effects overlap, as the figure below shows. Each correction works for several hours. Its effect on blood glucose can sometimes show up slowly, and it is tempting to give another small dose of insulin. In the end, 2–3 times more insulin than you really need at that moment can build up in your body.

The result usually shows up a few hours later, as a rapid fall in blood glucose that is hard to stop [2]. The practical safety rule is to wait until a correction has almost fully taken effect before giving the next one. Automated systems do this calculation on their own, which explains part of their protection against hypoglycemia [6].

Figure 1

What happens when two corrections overlap

The effect of two corrections given one hour apart and their combined effect Three curves over six hours. The first correction starts working after a few minutes, peaks at an hour and a half and ends after four and a half hours. The second correction, of the same size, given one hour later, has the same shape, shifted by one hour. The combined effect rises to about 175% of the peak of a single correction, a little over two hours after the first injection. It returns to zero only after five and a half hours. 0 1 2 3 4 5 6 Hours after the first correction Glucose-lowering effect (%) 0 50 100 150 200 peak of a single correction First Second Total
View the values as a table
The effect of each correction and the combined effect, hour by hour, as a percentage of the peak of a single correction
Hours after the first correctionFirst correctionSecond correctionCombined effect
00%0%0%
183%0%83%
289%83%172%
348%89%137%
47%48%55%
50%7%7%
60%0%0%
A schematic example, not a measurement. Each correction with a rapid-acting analog starts working after a few minutes, peaks somewhere within the first two hours and ends after 3–5 hours [4]. The second correction, of the same size, comes one hour later, when the first is only just approaching its peak. Their effects add up. The combined effect reaches about 175% of the peak of a single correction, a little over two hours after the first injection. This is where the rapid fall in blood glucose that is hard to stop comes from [2].

Can a wrong insulin-to-carbohydrate ratio cause hypoglycemia?

Yes. This ratio tells you how many grams of carbohydrates one unit of insulin covers. If the value you use gives too much insulin for the meal, your blood glucose falls two or three hours after you eat [1].

The pattern is easy to recognize because it shows up at the same meal, again and again. The ratio can differ between morning and evening and it changes over time, especially in children and teenagers [7]. It is changed together with your doctor, based on several days of observation [8].

Can an insulin sensitivity factor that is too low cause hypoglycemia?

Yes. The sensitivity factor tells you how much one unit of insulin lowers your blood glucose. If the value you use is lower than the real one, every correction will contain too much insulin [9].

The effect shows up after corrections, not after meals. Insulin sensitivity changes with body weight, physical activity and age [7] [8]. That is why this number is rechecked regularly, just like the insulin-to-carbohydrate ratio used for meals.

Does the injection site affect the risk of hypoglycemia?

Yes, more than most patients expect. Absorption is fastest from the abdomen, slower from the arm and slowest from the thigh and the buttock. An injection that goes into muscle by mistake is absorbed much faster and raises the risk of hypoglycemia [10].

The second problem is areas thickened by fat, which appear where you always inject in the same spot. Absorption from lipohypertrophy lumps is unpredictable, sometimes very slow and sometimes sudden [11]. These lumps occur in almost two thirds of patients who use insulin every day [12]. Unexplained hypoglycemia is much more common in people who have lipohypertrophy lumps [13].

A few simple measures protect you:

  • Correct rotation of injection sites, which is the strongest protective factor [12].
  • A new needle for every injection, because reusing the same needle also raises the risk [12].
  • Short 4 mm needles, which lower the chance of an injection into muscle [11].
  • Checking your injection sites at your checkups, at least once a year [11].

What do you do with your doses when your blood glucose keeps falling at the same time of day?

Gather the information and discuss it with your doctor. A pattern means at least 2–3 similar days, at the same time of day, with no obvious temporary cause. Write down the time, the value, the meal before it and your physical activity that day [14].

Patterns almost always have a simple solution, in this case probably a small reduction of the dose that acts in that time window [15]. The change is made in a single step and followed for a few days. Changing several doses at once makes it impossible to understand the result.

Who changes your insulin doses?

The doctor who follows you, together with you. Your doctor sets the doses, the treatment regimen and the adjustment rules you can apply on your own between checkups [11]. It is best if these rules are written down, personalized and tied to clear situations.

There is one universal exception, the time when your blood glucose is falling. In that case you take fast-acting carbohydrates right away [14]. A permanent change to a dose, however, remains a medical decision, because a change you make on your own can fix one hour and spoil the rest of the day.

How much do you reduce the dose after an episode of hypoglycemia?

This decision is made together with your doctor. The order of magnitude often used in practice is a small reduction, about 10–20% of the dose involved. Only one insulin dose is changed, usually the one that matches the time of the episode. After any adjustment, follow the effect for a few days, then discuss the result with your doctor so that the next step is as accurate as possible.

For a mild, isolated episode, its cause matters first [11]. If the cause is clear, such as unusual physical activity, there is usually no need to change the dose. A repeated pattern, however, calls for a careful review. A single level 2 or 3 episode is enough to reevaluate the treatment plan [14].

Conclusions

  • The time of hypoglycemia suggests the dose involved, such as basal insulin at night or on an empty stomach and the meal dose 2–3 hours after you eat [1].
  • Active insulin is checked before every correction, because corrections given close together add up and can lead to hypoglycemia that is hard to treat [2] [5].
  • Injection sites are rotated, with a new, short needle, because lipohypertrophy lumps make absorption unpredictable [11] [12].
  • The dose is adjusted together with your doctor, one dose at a time, and a level 2 or 3 episode calls for reviewing the treatment plan [14].

References

  1. Holt RIG, DeVries JH, Hess-Fischl A, et al. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44(11):2589-2625. PubMed
  2. Heise T, Meneghini LF. Insulin stacking versus therapeutic accumulation: understanding the differences. Endocr Pract. 2014;20(1):75-83. PubMed
  3. Ionescu-Tîrgoviște C, Guja C, Ioacara S, Dumitrescu D, Tomescu I. Continuous glucose monitoring: physiologic and pathophysiologic significance. Rom J Intern Med. 2004;42(2):381-393. PubMed
  4. Silva Júnior WS, Gabbay MAL, Lamounier RN, Calliari LE, Bertoluci MC. The 2021-2022 position of Brazilian Diabetes Society on insulin therapy in type 1 diabetes: an evidence-based guideline to clinical practice. Diabetol Metab Syndr. 2022;14(1):189. PubMed
  5. Walsh J, Roberts R, Heinemann L. Confusion Regarding Duration of Insulin Action: A Potential Source for Major Insulin Dose Errors by Bolus Calculators. J Diabetes Sci Technol. 2014;8(1):170-178. PubMed
  6. Bojoga I, Ioacara S, Malinici E, et al. Enhanced Metabolic Control in a Pediatric Population with Type 1 Diabetes Mellitus Using Hybrid Closed-Loop and Predictive Low-Glucose Suspend Insulin Pump Treatments. Pediatr Rep. 2024;16(4):1188-1199. PubMed
  7. Reinauer C, Welters A, Niemeyer M, et al. Age-Dependent Bolus Settings: Insulin-to-Carbohydrate Ratios and Insulin Sensitivity Factors in Pediatric Patients with Type 1 Diabetes on Conventional CSII in the DPV Registry. Diabetes Technol Ther. 2025;27(6):479-487. PubMed
  8. American Diabetes Association Professional Practice Committee. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S89-S131. PubMed
  9. Davidson PC, Hebblewhite HR, Steed RD, Bode BW. Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract. 2008;14(9):1095-1101. PubMed
  10. Gradel AKJ, Porsgaard T, Lykkesfeldt J, et al. Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability. J Diabetes Res. 2018;2018:1205121. PubMed
  11. Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2026 Sep 16. Online ahead of print. PubMed
  12. Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445-453. PubMed
  13. Mader JK, Fornengo R, Hassoun A, et al. Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing: A Systematic Meta-Analysis. Diabetes Technol Ther. 2024;26(5):351-362. PubMed
  14. American Diabetes Association Professional Practice Committee. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S132-S149. PubMed
  15. American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S150-S165. PubMed

How to cite this page

Ioacara S. Adjusting insulin doses to prevent hypoglycemia. Diabetes Academia. Updated October 2, 2026. https://diabetesacademia.com/t1dm/hypoglycemia-insulin-adjustment

Glossary terms used here